- Recommendation ID
Radical treatment of squamous cell carcinoma of the oesophagus:- Does the addition of surgery to chemoradiotherapy improve disease-free and overall survival in
people with squamous cell carcinoma of the oesophagus?
- Any explanatory notes
Why this is important:- The aetiology of squamous cell carcinoma (SCC) of the oesophagus is changing. Patients with SCC are now fitter, with fewer co-morbidities than in previous years. Standard radical treatment for SCC of the oesophagus is usually chemo-radiotherapy, which is associated with a median survival of between 12 and 18 months. Given a fitter patient population, surgery may be a therapeutic option but its effectiveness in addition to chemoradiotherapy is unknown and a randomised controlled study to investigate whether the combination improves disease-free and overall survival would provide useful information to guide future clinical practice.
Source guidance details
- Comes from guidance
- Oesophago-gastric cancer: assessment and management in adults
- Date issued
- January 2018
|Is this a recommendation for the use of a technology only in the context of research?||No|
|Is it a recommendation that suggests collection of data or the establishment of a register?||No|